cdactin,nivolumab,cabozantinib
miyarisan,bms,osel
['cabo ', 'nivo', 'rcc,(-irccs),(-srcc),(-urcc)', 'cbm588', 'arca, (-arcade)']
brilliant presentation by at #asco23 regarding the role of cbm588 with nivo/cabo in patients with mrcc. this, in conjunction with presentation last year, is really paving the way we will be treating patients with mrcc in the not-so-far future 
Medical Oncologist with interest in GU maligncies and disparities in cancer care/ @ASCO volunteer and @JCOGO_ASCO Editorial Fellow/ nuts about nuts